lanthionine ketimine has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hensley, K; Koehler, D; Shah, ZA; Williams, FE | 1 |
| Eslami, P; Gabbita, SP; Harris-White, ME; Hensley, K; Hristov, A; Johnson, MF; Venkova, K | 1 |
2 other study(ies) available for lanthionine ketimine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Lanthionine ketimine-5-ethyl ester provides neuroprotection in a zebrafish model of okadaic acid-induced Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acids, Sulfur; Animals; Brain; Cells, Cultured; Female; Male; Mice; Neuroprotection; Neuroprotective Agents; Okadaic Acid; Zebrafish | 2018 |
A derivative of the brain metabolite lanthionine ketimine improves cognition and diminishes pathology in the 3 × Tg-AD mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Amino Acids, Sulfur; Animals; Behavior, Animal; Brain; Cell Line, Tumor; Cognition; Disease Models, Animal; Female; Male; Maze Learning; Mice; Mice, Transgenic; Nesting Behavior; Neurons; Phosphorylation | 2013 |